Business Description
U2Bio Co Ltd
ISIN : KR7221800006
Compare
Compare
Traded in other countries / regions
221800.Korea IPO Date
2015-06-29Description
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 81.35 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.46 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.42 | |||||
| Beneish M-Score | -1.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.6 | |||||
| 3-Year EBITDA Growth Rate | -6.9 | |||||
| 3-Year Book Growth Rate | 62.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.23 | |||||
| 9-Day RSI | 53.46 | |||||
| 14-Day RSI | 47.23 | |||||
| 6-1 Month Momentum % | -35.94 | |||||
| 12-1 Month Momentum % | -47.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.64 | |||||
| Quick Ratio | 5.55 | |||||
| Cash Ratio | 4.6 | |||||
| Days Inventory | 12.68 | |||||
| Days Sales Outstanding | 106.09 | |||||
| Days Payable | 64.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.77 | |||||
| Dividend Payout Ratio | 0.44 | |||||
| Forward Dividend Yield % | 0.77 | |||||
| 5-Year Yield-on-Cost % | 0.8 | |||||
| 3-Year Average Share Buyback Ratio | -14.1 | |||||
| Shareholder Yield % | 1.07 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.69 | |||||
| Operating Margin % | -4.35 | |||||
| Net Margin % | 2.1 | |||||
| FCF Margin % | -11.47 | |||||
| ROE % | 1.83 | |||||
| ROA % | 1.34 | |||||
| ROIC % | -333.25 | |||||
| ROC (Joel Greenblatt) % | 2.68 | |||||
| ROCE % | 0.2 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 61.9 | |||||
| PE Ratio without NRI | 57.2 | |||||
| PS Ratio | 1.29 | |||||
| PB Ratio | 1.16 | |||||
| Price-to-Tangible-Book | 1.18 | |||||
| EV-to-EBIT | 103.13 | |||||
| EV-to-EBITDA | 7.73 | |||||
| EV-to-Revenue | 0.25 | |||||
| EV-to-FCF | -2.17 | |||||
| Price-to-Projected-FCF | 0.57 | |||||
| Price-to-Graham-Number | 1.73 | |||||
| Price-to-Net-Current-Asset-Value | 1.3 | |||||
| Price-to-Net-Cash | 1.72 | |||||
| Earnings Yield (Greenblatt) % | 0.97 | |||||
| FCF Yield % | -8.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
U2Bio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 30,792.036 | ||
| EPS (TTM) (â‚©) | 63 | ||
| Beta | 0.27 | ||
| Volatility % | 34.17 | ||
| 14-Day RSI | 47.23 | ||
| 14-Day ATR (â‚©) | 162.992565 | ||
| 20-Day SMA (â‚©) | 3845 | ||
| 12-1 Month Momentum % | -47.55 | ||
| 52-Week Range (â‚©) | 3720 - 10950 | ||
| Shares Outstanding (Mil) | 11.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
U2Bio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
U2Bio Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
U2Bio Co Ltd Frequently Asked Questions
What is U2Bio Co Ltd(XKRX:221800)'s stock price today?
The current price of XKRX:221800 is â‚©3900.00. The 52 week high of XKRX:221800 is â‚©10950.00 and 52 week low is â‚©3720.00.
When is next earnings date of U2Bio Co Ltd(XKRX:221800)?
The next earnings date of U2Bio Co Ltd(XKRX:221800) is .
Does U2Bio Co Ltd(XKRX:221800) pay dividends? If so, how much?
The Dividend Yield %  of U2Bio Co Ltd(XKRX:221800) is 0.77% (As of Today), Highest Dividend Payout Ratio of U2Bio Co Ltd(XKRX:221800) was 0.44. The lowest was 0.08. And the median was 0.38. The  Forward Dividend Yield % of U2Bio Co Ltd(XKRX:221800) is 0.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers